Biopharmaceutical company focused on the development of novel therapies based on the natural human hormone, uroguanylin, to treat gastrointestinal (GI) diseases and disorders
Location: United States, New York
Investors 2
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
| - | CRG | crglp.com |
Mentions in press and media 2
| Date | Title | Description | Source |
| 07.06.2017 | How a company could disrupt billion-dollar drug markets with... | Reuters/Brian Snyder An injection Advertisement Many of the powerful drugs used to treat autoimmu... | businessin... |
| 09.12.2016 | Synergy outlines upbeat PhIII data; Bluebird and Blue... | Synergy Pharmaceuticals $SGYP is following up on the late-stage success of its lead drug pl... | endpts.com... |